The U.S. Food and Drug Administration said on Friday it has approved Boehringer Ingelheim's drug for patients with a type of ...

In a letter to 93 manufacturers, Jeffrey Shuren, MD, director of the FDA's Center for Devices and Radiological Health, wrote that the agency was acting to reduce the number of underdoses ...